Related references
Note: Only part of the references are listed.Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum -lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
Wouter C. Rottier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores
S. Y. Park et al.
INFECTION (2011)
Estimating the Length of Hospitalization Attributable to Multidrug Antibiotic Resistance - Authors' Reply
Patrick D. Mauldin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study
C. Rubio-Terres et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China
Bijie Hu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Excess Costs and Utilization Associated with Methicillin Resistance for Patients with Staphylococcus aureus Infection
Gregory A. Filice et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Periprosthetic Joint Infection The Economic Impact of Methicillin-Resistant Infections
Javad Parvizi et al.
JOURNAL OF ARTHROPLASTY (2010)
Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus
E. Ott et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Clinical and Economic Outcomes in Patients With Community-Acquired Staphylococcus aureus Pneumonia
Charu Taneja et al.
JOURNAL OF HOSPITAL MEDICINE (2010)
Impact of Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections
Ya-Sung Yang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
Estimating the Length of Hospitalization Attributable to Multidrug Antibiotic Resistance
Stijn Blot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Are There Differences in Hospital Cost Between Patients With Nosocomial Methicillin-Resistant Staphylococcus aureus Bloodstream Infection and Those With Methicillin-Susceptible S-aureus Bloodstream Infection?
Debby Ben-David et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosa
Kathryn J. Eagye et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Clinical and Financial Outcomes Due to Methicillin Resistant Staphylococcus aureus Surgical Site Infection: A Multi-Center Matched Outcomes Study
Deverick J. Anderson et al.
PLOS ONE (2009)
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Anucha Apisarnthanarak et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Clinical and economic impact of common multidrug-resistant gram-negative bacilli
Christian G. Giske et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia:: a systematic review and meta-analysis
Mitchell J. Schwaber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia
Nan-Yao Lee et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Clinical impact of infections caused by ESBL-producing E coli and K pneumoniae
Axel Kola et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients
W. Greiner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs:: A matched cohort study
Su Young Lee et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia
TP Lodise et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia
SD Reed et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
The impact of methicillin-resistance in Staphylococcus aureus bacteremia on patient outcomes:: Mortality, length of stay, and hospital charges
SE Cosgrove et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections
BJ Kopp et al.
ANNALS OF PHARMACOTHERAPY (2004)
Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU:: risk factors, morbidity and cost
D Lepelletier et al.
PATHOLOGIE BIOLOGIE (2004)
Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections
CG McHugh et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection
JJ Engemann et al.
CLINICAL INFECTIOUS DISEASES (2003)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
